InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,158.04
(
0.59%
)
US TECH 100
17,516.68
(
0.56%
)
Dow Jones
38,810.64
(
0.35%
)
Brent Oil
83.41
(
0.34%
)
Bitcoin
64,091.24
(
0.14%
)
Post# of 12410
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

PK holder

Send PM Follow Ignore
Followers 9
Posts 649
Boards Moderated 0
Alias Born 08/24/2011

PK holder

Re: None

Thursday, 03/09/2017 10:14:39 AM

Thursday, March 09, 2017 10:14:39 AM

Post# of 12410
One of the things I'm taking away from this. If the trials started 2/16 and they are still looking for people we can then safely say that is is safe from a toxicity and/or morbid point of view of AAGP in humans. They would not let the trials continue if the first patient didn't fair well.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!